Array BioPharma Inc. (NASDAQ:ARRY): Up to Date Analyst Ratings
Array BioPharma Inc. (NASDAQ:ARRY) registered a -5.18% decrease, still its new closing price is 345.80% up from the company’s 1 year high of 11.65.It posted …
Posts tagged NASDAQ:ARRY
Why Array Biopharma (NASDAQ:ARRY) have been downgraded?
Array Biopharma Inc (NASDAQ:ARRY) currently trades at $10.61 which is about -5.18% lower than the 52-week high of $11.65. The trading volume at ready counter …
Analyst Coverage That Needs Your Attention: Array BioPharma Inc. (NASDAQ:ARRY), Zions Bancorporation (NASDAQ:ZION)
Array BioPharma Inc. (NASDAQ:ARRY) showed a growth of 1.27% from the market’s prior closing price. That gain sent the price at $11.19 per share as …
These Brokerage Research Findings Are Noteworthy: Array BioPharma Inc. (NASDAQ:ARRY), Bonanza Creek Energy Inc. (NYSE:BCEI)
Array BioPharma Inc. (NASDAQ:ARRY) showed a growth of 0.09% from the market’s prior closing price. That gain sent the price at $11.25 per share as …